← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Reneurogen, Llc
Elm Grove, WI
$4,526,304
Total funding
4
Grants
Funding over time
peak $1.9M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,526,304 · 4
By mechanism
R44$3,966,024 · 2
R43$560,280 · 2
Investigators at Reneurogen, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of a systems pharmacology agent for treatment of bronchopulmonary dysplasia$1,861,772
R44 · FY2024 · HL
KYC, an inhibitor of sickle cell disease's vicious cycle in vaso-occlusive crisis and pain$1,045,688
R44 · FY2025 · HL
Development of a systems pharmacology agent for treatment of bronchopulmonary dysplasia$1,008,564
R44 · FY2023 · HL
A Novel Myeloperoxidase Inhibitor for Treating Multiple Sclerosis$285,790
R43 · FY2018 · NS
KYC Reduces Vasculopathy in Sickle Cell Disease$274,490
R43 · FY2018 · HL
Development of a systems pharmacology agent for treatment of bronchopulmonary dysplasia$50,000
R44 · FY2025 · HL